Back to feedArs Technica - All contentTechnologynewsModerna's mRNA flu shot earns FDA approval after rollercoaster reviewThursday, August 6, 2026 Beth Mole View original––– Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
